PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.80%
Revenue growth above 1.5x STERV.HE's 1.72%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
25.99%
Positive gross profit growth while STERV.HE is negative. John Neff would see a clear operational edge over the competitor.
-1760.00%
Negative EBIT growth while STERV.HE is at 151.99%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-123.53%
Negative operating income growth while STERV.HE is at 161.29%. Joel Greenblatt would press for urgent turnaround measures.
4.11%
Net income growth under 50% of STERV.HE's 133.24%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.11%
Share reduction while STERV.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-4.11%
Reduced diluted shares while STERV.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
100.00%
Positive FCF growth while STERV.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-14.93%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
7.18%
5Y revenue/share CAGR similar to STERV.HE's 7.02%. Walter Schloss might see both companies benefiting from the same mid-term trends.
-16.09%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.00%
Negative 10Y OCF/share CAGR while STERV.HE stands at 190.38%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while STERV.HE is at 112.67%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-122.22%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-133.33%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-106.42%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
76.98%
10Y equity/share CAGR at 75-90% of STERV.HE's 94.56%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
41.98%
5Y equity/share CAGR at 75-90% of STERV.HE's 47.95%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
6.66%
Positive short-term equity growth while STERV.HE is negative. John Neff sees a strong advantage in near-term net worth buildup.
-41.67%
Cut dividends over 10 years while STERV.HE stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-82.93%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-100.00%
Firm’s AR is declining while STERV.HE shows 15.33%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Inventory is declining while STERV.HE stands at 13.56%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.06%
Asset growth above 1.5x STERV.HE's 1.77%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
68.69%
BV/share growth above 1.5x STERV.HE's 2.44%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-100.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.